Cargando…
Surgical indications and clinical management of benign and malignant follicular thyroid tumors: An algorithmic-based approach
The present study retrospectively reviewed the treatment courses and results of patients with follicular thyroid tumors, including carcinomas. In the 5 year study period from April 2015 to March 2020, 797 patients with differentiated thyroid carcinoma and 128 patients with follicular tumors (FTs) re...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7783721/ https://www.ncbi.nlm.nih.gov/pubmed/33414913 http://dx.doi.org/10.3892/mco.2020.2194 |
_version_ | 1783632166488375296 |
---|---|
author | Iwasaki, Hiroyuki Toda, Soji Murayama, Daisuke Kato, Shin Matsui, Ai |
author_facet | Iwasaki, Hiroyuki Toda, Soji Murayama, Daisuke Kato, Shin Matsui, Ai |
author_sort | Iwasaki, Hiroyuki |
collection | PubMed |
description | The present study retrospectively reviewed the treatment courses and results of patients with follicular thyroid tumors, including carcinomas. In the 5 year study period from April 2015 to March 2020, 797 patients with differentiated thyroid carcinoma and 128 patients with follicular tumors (FTs) received surgery or treatment for distant metastases and recurrence at the Kanagawa Cancer Center (Japan). Of these patients, 73 that were diagnosed with follicular thyroid carcinoma (FTC) were included in the present study. An algorithm used for the application of treatment strategies was assessed. The aim of the present study was to examine patients with FT or FTC who were treated at the Kanagawa Cancer Center to devise appropriate treatment strategies and to evaluate the various treatment outcomes of FTC. Pre-diagnostic serum thyroglobulin and thyroid stimulating hormone levels, follow-up and overall survival (OS) were investigated in the present study. The results revealed that OS was significantly increased in patients with minimally invasive follicular thyroid cancer (MIFTC) compared with widely invasive follicular thyroid cancer (WIFTC) (log-rank test, P=0.017). Additionally, OS was significantly higher in patients without distant metastasis at the first consultation compared with those initially diagnosed with distant metastasis (log-rank test, P=0.023). Although all patients without distant metastasis at the first consultation and those with MIFTC are alive, the 10-year survival rates were 75.3% for patients with WIFTC and 75.6% for those with distant metastasis at the first consultation. The results of the present study suggested that the prognosis of WIFTC was the worst among patients with FTC and distant metastasis, and that total thyroidectomy surgery and radioactive iodine treatment are essential. Additionally, if the disease progresses, prompt inclusion of tyrosine kinase inhibitor therapy is necessary. |
format | Online Article Text |
id | pubmed-7783721 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | D.A. Spandidos |
record_format | MEDLINE/PubMed |
spelling | pubmed-77837212021-01-06 Surgical indications and clinical management of benign and malignant follicular thyroid tumors: An algorithmic-based approach Iwasaki, Hiroyuki Toda, Soji Murayama, Daisuke Kato, Shin Matsui, Ai Mol Clin Oncol Articles The present study retrospectively reviewed the treatment courses and results of patients with follicular thyroid tumors, including carcinomas. In the 5 year study period from April 2015 to March 2020, 797 patients with differentiated thyroid carcinoma and 128 patients with follicular tumors (FTs) received surgery or treatment for distant metastases and recurrence at the Kanagawa Cancer Center (Japan). Of these patients, 73 that were diagnosed with follicular thyroid carcinoma (FTC) were included in the present study. An algorithm used for the application of treatment strategies was assessed. The aim of the present study was to examine patients with FT or FTC who were treated at the Kanagawa Cancer Center to devise appropriate treatment strategies and to evaluate the various treatment outcomes of FTC. Pre-diagnostic serum thyroglobulin and thyroid stimulating hormone levels, follow-up and overall survival (OS) were investigated in the present study. The results revealed that OS was significantly increased in patients with minimally invasive follicular thyroid cancer (MIFTC) compared with widely invasive follicular thyroid cancer (WIFTC) (log-rank test, P=0.017). Additionally, OS was significantly higher in patients without distant metastasis at the first consultation compared with those initially diagnosed with distant metastasis (log-rank test, P=0.023). Although all patients without distant metastasis at the first consultation and those with MIFTC are alive, the 10-year survival rates were 75.3% for patients with WIFTC and 75.6% for those with distant metastasis at the first consultation. The results of the present study suggested that the prognosis of WIFTC was the worst among patients with FTC and distant metastasis, and that total thyroidectomy surgery and radioactive iodine treatment are essential. Additionally, if the disease progresses, prompt inclusion of tyrosine kinase inhibitor therapy is necessary. D.A. Spandidos 2021-02 2020-12-17 /pmc/articles/PMC7783721/ /pubmed/33414913 http://dx.doi.org/10.3892/mco.2020.2194 Text en Copyright: © Iwasaki et al. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. |
spellingShingle | Articles Iwasaki, Hiroyuki Toda, Soji Murayama, Daisuke Kato, Shin Matsui, Ai Surgical indications and clinical management of benign and malignant follicular thyroid tumors: An algorithmic-based approach |
title | Surgical indications and clinical management of benign and malignant follicular thyroid tumors: An algorithmic-based approach |
title_full | Surgical indications and clinical management of benign and malignant follicular thyroid tumors: An algorithmic-based approach |
title_fullStr | Surgical indications and clinical management of benign and malignant follicular thyroid tumors: An algorithmic-based approach |
title_full_unstemmed | Surgical indications and clinical management of benign and malignant follicular thyroid tumors: An algorithmic-based approach |
title_short | Surgical indications and clinical management of benign and malignant follicular thyroid tumors: An algorithmic-based approach |
title_sort | surgical indications and clinical management of benign and malignant follicular thyroid tumors: an algorithmic-based approach |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7783721/ https://www.ncbi.nlm.nih.gov/pubmed/33414913 http://dx.doi.org/10.3892/mco.2020.2194 |
work_keys_str_mv | AT iwasakihiroyuki surgicalindicationsandclinicalmanagementofbenignandmalignantfollicularthyroidtumorsanalgorithmicbasedapproach AT todasoji surgicalindicationsandclinicalmanagementofbenignandmalignantfollicularthyroidtumorsanalgorithmicbasedapproach AT murayamadaisuke surgicalindicationsandclinicalmanagementofbenignandmalignantfollicularthyroidtumorsanalgorithmicbasedapproach AT katoshin surgicalindicationsandclinicalmanagementofbenignandmalignantfollicularthyroidtumorsanalgorithmicbasedapproach AT matsuiai surgicalindicationsandclinicalmanagementofbenignandmalignantfollicularthyroidtumorsanalgorithmicbasedapproach |